黑料网

Journal of Oncology Research and Treatment
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Commentary   
  • J oncol Res Treat,
  • DOI: 10.4172/aot.1000168

To Remember the Importance of both Donor Choice and HLA Matching to Reduce Morbidity and Mortality after Allogeneic Hematopoietic Stem Cell Transplant (HSCT)

Marie Detrait*
Hematology Department, CHRU Nancy, Hôpitaux de Brabois, Nancy, France
*Corresponding Author : Dr. Marie Detrait, Hematology Department, CHRU Nancy, Hôpitaux de Brabois, Nancy, France, Tel: 33383154377, Email: detraitmarie@gmail.com

Received Date: Sep 15, 2021 / Accepted Date: Sep 29, 2021 / Published Date: Oct 05, 2021

Keywords: Hematopoietic Stem Cell Transplant (HSCT)

Citation: Detrait M (2021) To Remember the Importance of both Donor Choice and HLA Matching to Reduce Morbidity and Mortality after Allogeneic Hematopoietic Stem Cell Transplant (HSCT) J Oncol Res Treat 6:168. Doi: 10.4172/aot.1000168

Copyright: © 2021 Detrait M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top